References
Benson AB, Venook AP, Al-Hawary MM, et al. Colon Cancer, version 2.2021, NCCN Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329–59. https://doi.org/10.6004/jnccn.2021.0012.
Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(12):1208–15. https://doi.org/10.1016/S1470-2045(13)70447-9.
Sarkar J, Attwood K, Schwarz RE. Perioperative chemotherapy is associated with superior overall survival in patients with synchronous colorectal liver metastases. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14302-9.
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–18. https://doi.org/10.1097/00000658-199909000-00004.
Ninomiya M, Emi Y, Motomura T, et al. Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases. Int J Clin Oncol. 2021;26(12):2255–64. https://doi.org/10.1007/s10147-021-02024-5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sarkar, J., Schwarz, R.E. ASO Author Reflections: Optimizing Treatment Sequencing in Synchronous Resectable Colorectal Liver Metastases. Ann Surg Oncol 31, 156–157 (2024). https://doi.org/10.1245/s10434-023-14410-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14410-6